MORPHABOND ER Is a Single-Agent, Abuse-Deterrent Morphine

MORPHABOND ER Is a Single-Agent, Abuse-Deterrent Morphine1,2

Familiar efficacy and safety


Bioequivalent to MS Contin®

FDA approved based on efficacy and safety of MS Contin® (reference listed drug)

Familiar dosing


A 1-to-1 conversion from MS Contin®

Taken orally every 8 or 12 hours

Available in 15 mg, 30 mg, 60 mg, and 100 mg

MORPHABOND ER With SentryBond Technology Has Multiple Overlapping Abuse-Deterrent Barriers1,2

Inactive ingredients make MORPHABOND ER more difficult to crush, dissolve, and syringe vs MS Contin®

Retains its extended-release properties even if manipulated

Expected to deter abuse by both of the following routes:

Abuse of MORPHABOND ER is still possible by intranasal, intravenous, and oral routes

Morphabond ER Navigation